v3.25.3
Stockholder's Equity (Tables)
9 Months Ended
Sep. 28, 2025
Equity [Abstract]  
Share-Based Payment Arrangement, Activity
The following table summarizes the number of stock-based awards granted by the Company and the weighted-average grant-date fair value per unit for the three-month and nine-month periods ended September 28, 2025 and September 29, 2024:
Three-months EndedNine-months Ended
September 28, 2025September 29, 2024September 28, 2025September 29, 2024
Stock-Based Awards Granted
(in 
thousands)
Weighted-
Average
Grant-Date Fair Value
Stock-Based Awards Granted
(in 
thousands)
Weighted-
Average
Grant-Date Fair Value
Stock-Based Awards Granted
(in
 thousands)
Weighted-
Average
Grant-Date Fair Value
Stock-Based Awards Granted
(in 
thousands)
Weighted-
Average
Grant-Date Fair Value
Stock options30 $17.03 21 $14.75 1,669 $12.14 1,641 $14.89 
Restricted stock units54 $43.51 41 $36.40 1,313 $32.77 838 $38.90 
Performance restricted stock units $ — $— 184 $32.14 55 $39.05 
84 62 3,166 2,534 
Stock-Based Compensation Expense
The following table presents the stock-based compensation expense by caption for each period presented on the Consolidated Statements of Operations (in thousands):
Three-months EndedNine-months Ended
September 28, 2025September 29, 2024September 28, 2025September 29, 2024
Cost of revenue$489 $442 $1,694 $1,460 
Research, development, and engineering3,794 3,707 11,933 11,636 
Selling, general, and administrative8,133 8,952 21,022 26,271 
Total stock-based compensation expense$12,416 $13,101 $34,649 $39,367